EverGlade Consulting helps land up to $1 billion in BARDA funding for biotech company
CHARLESTON, SC, November 8, 2022 /PRNewswire/ — EverGlade Consulting (“EverGlade”), a national consulting firm, has helped a leading biotechnology company land a Biomedical Advanced Research and Development Authority (BARDA) award with potential $1 billion in federal funding. This multi-year contract will allow the Company to advance the development of a comprehensive portfolio of innovative solutions to combat influenza and other infectious disease threats.
As part of BARDA’s ongoing efforts to prepare for and respond to public health emergencies, the agency initially partnered with the company for the continued and rapid development of an investigational prophylactic monoclonal antibody (mAb) designed to protect against seasonal and pandemic influenza.
“I am thrilled that our team was able to contribute to this vital BARDA initiative,” said the EverGlade founder. Eric Jia Sobota. “This award responds to a critical need for preparedness before the next pandemic.”
The BARDA award is an Other Transaction Authority (OTA) agreement that also contains additional options to support the development of up to 10 medical countermeasures for other pathogens with pandemic potential and/or chemical, biological, radiological and nuclear.
Andrew Stiles, Director of EverGlade, said, “This OTA provides great flexibility that will allow BARDA and society to act quickly and accelerate the development of medical countermeasures to quickly respond to future public health emergencies. It’s great to see the government being creative in contracting vehicles to bolster our national health security.”
About EverGlade Consulting
EverGlade Consulting is a national consulting firm that helps clients navigate the federal landscape. We work with technology-focused companies whose goal is to secure non-dilutive funding through the federal government. We offer services ranging from opportunity identification and proposal assistance to implementing systems to comply with federal regulations at agencies such as BARDA, ASPR, NIH, DTRA, JPEO, and DARPA.
For more information about EverGlade Consulting, visit:
For more information on EverGlade’s recent success, visit:
Contact: [email protected]